Bristol-Myers Squibb Income Statement
View: Annual | Quarterly
| Quarter Ending Sep 09 |
Quarter Ending Jun 09 |
Quarter Ending Jun 09 |
Quarter Ending Mar 09 |
Quarter Ending Mar 09 |
|
|---|---|---|---|---|---|
| Revenue | 5,487.0 | 5,384.0 | 5,384.0 | 5,015.0 | 5,015.0 |
| Cost of Goods Sold | 1,562.0 | 1,461.0 | 1,461.0 | 1,413.0 | 1,413.0 |
| Gross Profit | 3,925.0 | 3,923.0 | 3,923.0 | 3,602.0 | 3,602.0 |
| Gross Profit Margin | 71.5% | 72.9% | 72.9% | 71.8% | 71.8% |
| SG&A Expense | 1,478.0 | 1,505.0 | 1,505.0 | 1,492.0 | 1,492.0 |
| Depreciation & Amortization | -- | -- | 332.0 | -- | -- |
| Operating Income | -- | -- | -- | 1,436.0 | 1,436.0 |
| Operating Margin | -- | -- | -- | 28.6% | 28.6% |
| Nonoperating Income | -- | -- | -- | 263.0 | 263.0 |
| Nonoperating Expenses | -- | -- | -- | (39.0) | (39.0) |
| Income Before Taxes | 1,724.0 | 1,741.0 | 1,741.0 | 1,384.0 | 1,384.0 |
| Income Taxes | 434.0 | 443.0 | 443.0 | 463.0 | 463.0 |
| Net Income After Taxes | 1,290.0 | 1,298.0 | 1,298.0 | 921.0 | 921.0 |
| Continuing Operations | 1,290.0 | 1,298.0 | 1,298.0 | 921.0 | 921.0 |
| Discontinued Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Operations | 1,290.0 | 1,298.0 | 1,298.0 | 921.0 | 921.0 |
| Total Net Income | 1,290.0 | 1,298.0 | 1,298.0 | 921.0 | 921.0 |
| Net Profit Margin | 23.5% | 24.1% | 24.1% | 18.4% | 18.4% |
| Diluted EPS from Total Net Income ($) | 0.48 | 0.49 | 0.49 | 0.32 | 0.32 |
| Dividends per Share | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 |
© 2009 Morningstar, Inc. Financial Data provided by
